CHINO HILLS, CALIFORNIA / ACCESS Newswire / May 6, 2025 /SOHM, Inc. (OTC PINK:SHMN), a biotech company at the forefront of precision cellular engineering, announced today the successful development of ...

Results from studies at Virginia Commonwealth University (VCU) show that an Aramchol and Bayer's Regorafenib drug combination significantly reduced hepatic tumor ...

CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated ...

The FDA’s decision to ban dyes and other synthetic substances often rests on the Delaney clause, a 49‑word law from 1958 that ...

Erin Patterson is facing trial after pleading not guilty over a fatal mushroom lunch. Today, Nanette Rogers, SC, will present ...

The authors found that in 2023 there were 93 million CTs done on 62 million patients. The total estimated lifetime number of ...

Illuccix’s broad approval is supported by robust clinical data, including the largest Ga-68-based PSMA data set from the VISION trial 6. The approval of Illuccix® in France has the potential to ...

A new analysis estimates that more than 100,000 cancer cases per year could be caused by radiation from CT scans. In some cases, the information provided by a CT scan could also be obtained from ...

Here three mothers, who've not had the disease, and their daughters, all recently diagnosed, talk frankly about their ...